Extracellular Vesicles—Roles in Metastasis and Mediation of Cellular Cross Talk

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Microenvironment".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 7583

Special Issue Editor


E-Mail Website
Guest Editor
Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar
Interests: cancer; metastasis; drug resistance; miRNA
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Research in the past several years has firmly established the importance of extracellular vesicles, particularly exosomes, as mediators of cell-to-cell communications within the tumor microenvironment. Acting as cargos, these vesicles shuttle critical molecules, including, proteins and RNA, from one cell to another, thus playing an important role in cellular cross talk. The delivery of cargo contents to recipient cells influences many fundamental physiological processes affecting growth, proliferation, apoptosis, cell cycle and response to therapies. Cancer metastasis is a major reason for cancer-associated mortality, and the role of extracellular vesicles, particularly, exosomes, in cancer metastasis is increasingly being realized. Mediating the cellular cross talk, exosomes deliver pro-metastatic factors that facilitate increased migration and invasion of tumor cells resulting in increased metastasis. The cargo can also consist of factors that mitigate the effects of anti-metastatic machinery. Additionally, in a true bi-directional cross talk, exosomes from tumor cells can ‘transform’ the cells in their immediate vicinity, such as fibroblasts, immune cells, etc., to turn pro-tumorigenic, which, in turn, communicate back with tumor cells, through exosomes, thus supporting metastasis. This Special Issue focuses on the role of extracellular vesicles in cellular cross talk leading to the alteration of the metastatic potential of tumor cells, which can potentially open up new avenues for the targeted therapy of metastatic cancers.

Dr. Aamir Ahmad
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • extracellular vesicles
  • exosomes
  • metastasis
  • tumor microenvironment
  • tumor immune response
  • tumor-associated macrophages
  • cancer-associated fibroblasts
  • pro-metastatic
  • anti-metastatic

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 2302 KiB  
Review
Exosomes as a Nano-Carrier for Chemotherapeutics: A New Era of Oncology
by Rodrigo Pinheiro Araldi, Denis Adrián Delvalle, Vitor Rodrigues da Costa, Anderson Lucas Alievi, Michelli Ramires Teixeira, João Rafael Dias Pinto and Irina Kerkis
Cells 2023, 12(17), 2144; https://doi.org/10.3390/cells12172144 - 25 Aug 2023
Cited by 4 | Viewed by 2612
Abstract
Despite the considerable advancements in oncology, cancer remains one of the leading causes of death worldwide. Drug resistance mechanisms acquired by cancer cells and inefficient drug delivery limit the therapeutic efficacy of available chemotherapeutics drugs. However, studies have demonstrated that nano-drug carriers (NDCs) [...] Read more.
Despite the considerable advancements in oncology, cancer remains one of the leading causes of death worldwide. Drug resistance mechanisms acquired by cancer cells and inefficient drug delivery limit the therapeutic efficacy of available chemotherapeutics drugs. However, studies have demonstrated that nano-drug carriers (NDCs) can overcome these limitations. In this sense, exosomes emerge as potential candidates for NDCs. This is because exosomes have better organotropism, homing capacity, cellular uptake, and cargo release ability than synthetic NDCs. In addition, exosomes can serve as NDCs for both hydrophilic and hydrophobic chemotherapeutic drugs. Thus, this review aimed to summarize the latest advances in cell-free therapy, describing how the exosomes can contribute to each step of the carcinogenesis process and discussing how these nanosized vesicles could be explored as nano-drug carriers for chemotherapeutics. Full article
Show Figures

Figure 1

27 pages, 4081 KiB  
Review
Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis
by Goffredo O. Arena, Stefano Forte, Mohamed Abdouh, Cheryl Vanier, Denis Corbeil and Aurelio Lorico
Cells 2023, 12(12), 1566; https://doi.org/10.3390/cells12121566 - 6 Jun 2023
Cited by 10 | Viewed by 4429
Abstract
Metastases are responsible for the vast majority of cancer deaths, yet most therapeutic efforts have focused on targeting and interrupting tumor growth rather than impairing the metastatic process. Traditionally, cancer metastasis is attributed to the dissemination of neoplastic cells from the primary tumor [...] Read more.
Metastases are responsible for the vast majority of cancer deaths, yet most therapeutic efforts have focused on targeting and interrupting tumor growth rather than impairing the metastatic process. Traditionally, cancer metastasis is attributed to the dissemination of neoplastic cells from the primary tumor to distant organs through blood and lymphatic circulation. A thorough understanding of the metastatic process is essential to develop new therapeutic strategies that improve cancer survival. Since Paget’s original description of the “Seed and Soil” hypothesis over a hundred years ago, alternative theories and new players have been proposed. In particular, the role of extracellular vesicles (EVs) released by cancer cells and their uptake by neighboring cells or at distinct anatomical sites has been explored. Here, we will outline and discuss these alternative theories and emphasize the horizontal transfer of EV-associated biomolecules as a possibly major event leading to cell transformation and the induction of metastases. We will also highlight the recently discovered intracellular pathway used by EVs to deliver their cargoes into the nucleus of recipient cells, which is a potential target for novel anti-metastatic strategies. Full article
Show Figures

Figure 1

Back to TopTop